LBRX 424B3: Cfo change
LB Pharmaceuticals Inc.
Filed with the SEC on · accession 0001193125-26-381100
LBRX filed a 424B3 (prospectus (offering)) with the SEC on Sep 3, 2026. LB Pharmaceuticals Inc. announced the appointment of Joseph M. The stock moved -4.0% by the first close after the filing.
Summary of the filing
LB Pharmaceuticals Inc. announced the appointment of Joseph M. Miller as Chief Financial Officer, effective September 2, 2026. Mr. Miller brings over two decades of experience in the biotech and pharmaceutical sectors, most recently serving as CFO of Aurinia Pharmaceuticals Inc.
Key details
How LBRX stock reacted
Close before
$49.48
Sep 2, 2026
First close after
-3.96%
$47.52
5 trading days
-6.53%
$46.25
Since filing
-17.50%
$40.82
✦ Ask GOAX AI about this filing — what it means for LBRX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for LBRX?
Click hereFrequently asked questions
What did LBRX file with the SEC on Sep 3, 2026?
LBRX filed a 424B3 (Cfo change). LB Pharmaceuticals Inc. announced the appointment of Joseph M. Miller as Chief Financial Officer, effective September 2, 2026. Mr. Miller brings over two decades of experience in the biotech and pharmaceutical sectors, most recently serving as CFO of Aurinia Pharmaceuticals Inc.
What does a cfo change mean for LBRX stock?
Not always. A planned retirement with a successor is usually calm; a sudden departure “effective immediately”, especially of a CFO or near results, often worries investors.
How do I read a 424B3?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B3 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did LBRX stock react to this filing?
LBRX closed at $49.48 before the filing and $47.52 on Sep 3, 2026 (-3.96%). Five trading days later: $46.25 (-6.53%).
Other LBRX SEC filings
- 10-Q · SEC filingNov 5, 2026
- 8-K · SEC filingNov 5, 2026
- EFFECT · Shelf registrationOct 5, 2026
- 8-K · Executive departureSep 15, 2026
- 424B3 · Executive departureSep 15, 2026
- 8-K · Cfo changeSep 3, 2026
- 8-K · SEC filingAug 11, 2026
- 10-Q · SEC filingAug 11, 2026
- 424B3 · Secondary offeringAug 11, 2026
- 424B3 · Secondary offeringJul 29, 2026
Get alerts when LBRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days